ETS1 regulates NKX3.1 5′ promoter activity and expression in prostate cancer cells

Prostate

Volumn 71, Issue 4, 2011, Pages 403-414

  Preece, Darren M ^a   Harvey, Jennet M ^b   Bentel, Jacqueline M ^a   Thomas, Marc A ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

ETS family; gene expression; prostate cancer; transcriptional regulation

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR ETS 1;

ADULT; ANALYSIS; ARTICLE; BINDING SITE; BIOINFORMATICS; CANCER CELL; CANCER CELL CULTURE; CELL STRAIN LNCAP; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DOWN REGULATION; DRUG BINDING; EPITHELIUM CELL; GEL MOBILITY SHIFT ASSAY; GENE; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE LOCATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; NKX3.1 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN BLOOD LEVEL; REPORTER GENE; UPREGULATION; WESTERN BLOTTING;

CELL LINE, TUMOR; HOMEODOMAIN PROTEINS; HUMANS; MALE; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEIN C-ETS-1; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 79251507656     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21254     Document Type: Article

References (48)

1. Crawford ED,. Epidemiology of prostate cancer. Urology 2003; 62: 3-12.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ,. Cancer statistics. Cancer J Clin 2006; 56 (2): 106-130.
3. Dong JT,. Prevalent mutations in prostate cancer. J Cell Biochem 2006; 97 (3): 433-447.
4. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, Norton CR, Gridley T, Cardiff RD, Cunha GR, Abate-Shen C, Shen MM,. Roles for Nkx3.1 in prostate development and cancer. Genes Dev 1999; 13 (8): 966-977.
5. Tanaka M, Komuro I, Inagaki H, Jenkins NA, Copeland NG, Izumo S,. Nkx3.1, a murine homolog of Drosophila bagpipe, regulates epithelial ductal branching and proliferation of the prostate and palatine glands. Dev Dyn 2000; 219 (2): 248-260.
6. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA, Linehan WM,. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 1995; 55 (14): 2959-2962.
7. He WW, Sciavolino PJ, Wing J, Augustus M, Hudson P, Meissner PS, Curtis RT, Shell BK, Bostwick DG, Tindall DJ, Gelmann EP, Abate-Shen C, Carter KC,. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics 1997; 43 (1): 69-77.
8. Vocke CD, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, Duray PH, Liotta LA, Emmert-Buck MR, Linehan WM,. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res 1996; 56 (10): 2411-2416.
9. Aslan G, Irer B, Tuna B, Yorukoglu K, Saatcioglu F, Celebi I,. Analysis of NKX3.1 expression in prostate cancer tissues and correlation with clinicopathologic features. Pathol Res Pract 2006; 202 (2): 93-98.
10. Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi OP, Gelmann EP,. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res 2000; 60 (21): 6111-6115.
11. Abdulkadir SA, Magee JA, Peters TJ, Kaleem Z, Naughton CK, Humphrey PA, Milbrandt J,. Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia. Mol Cell Biol 2002; 22 (5): 1495-1503.
12. Kim MJ, Bhatia-Gaur R, Banach-Petrosky WA, Desai N, Wang Y, Hayward SW, Cunha GR, Cardiff RD, Shen MM, Abate-Shen C,. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res 2002; 62 (11): 2999-3004.
13. Gao H, Ouyang X, Banach-Petrosky W, Borowsky AD, Lin Y, Kim M, Lee H, Shih WJ, Cardiff RD, Shen MM, Abate-Shen C,. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 2004; 101 (49): 17204-17209.
14. Gary B, Azuero R, Mohanty GS, Bell WC, Eltoum IE, Abdulkadir SA,. Interaction of Nkx3.1 and p27kip1 in prostate tumor initiation. Am J Pathol 2004; 164 (5): 1607-1614.
15. Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, Shen MM, Abate-Shen C,. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 2002; 99 (5): 2884-2889.
16. Abate-Shen C, Banach-Petrosky WA, Sun X, Economides KD, Desai N, Gregg JP, Borowsky AD, Cardiff RD, Shen MM,. Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res 2003; 63 (14): 3886-3890.
17. Lei Q, Jiao J, Xin L, Chang CJ, Wang S, Gao J, Gleave ME, Witte ON, Liu X, Wu H,. NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss. Cancer Cell 2006; 9 (5): 367-378.
18. Asatiani E, Huang WX, Wang A, Rodriguez Ortner E, Cavalli LR, Haddad BR, Gelmann EP,. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Res 2005; 65 (4): 1164-1173.
19. Lind GE, Skotheim RI, Fraga MF, Abeler VM, Henrique R, Saatcioglu F, Esteller M, Teixeira MR, Lothe RA,. The loss of NKX3.1 expression in testicularâand prostateâcancers is not caused by promoter hypermethylation. Mol Cancer 2005; 4 (1): 8.
20. Jiang AL, Zhang JY, Young C, Hu XY, Wang YM, Liu ZF, Hao ML,. Molecular cloning and characterization of human homeobox gene Nkx3.1 promoter. Acta Biochim Biophys Sin (Shanghai) 2004; 36 (1): 64-67.
21. Jiang AL, Zhang PJ, Hu XY, Chen WW, Kong F, Liu ZF, Yuan HQ, Zhang JY,. Identification of a positive Cis-element upstream of human NKX3.1 gene. Acta Biochim Biophys Sin (Shanghai) 2005; 37 (11): 773-778.
22. Anli J, Pengju Z, Xiaoyan H, Wenwei C, Zhifang L, Feng K, Huiqing Y, Jianye Z,. Identification of an inhibitory cis-element in the promoter region of human homeobox gene NKX3.1. Prostate 2006; 66 (12): 1339-1346.
23. Jiang A, Yu C, Zhang P, Chen W, Liu W, Hu X, Zhang J,. p53 overexpression represses androgen-mediated induction of NKX3.1 in a prostate cancer cell line. Exp Mol Med 2006; 38 (6): 625-633.
24. Thomas MA, Hodgson MC, Loermans SD, Hooper J, Endersby R, Bentel JM,. Transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells. J Cell Biochem 2006; 99 (5): 1409-1419.
25. Jiang AL, Zhang PJ, Chen WW, Liu WW, Yu CX, Hu XY, Zhang XQ, Zhang JY,. Effects of 9-cis retinoic acid on human homeobox gene NKX3.1 expression in prostate cancer cell line LNCaP. Asian J Androl 2006; 8 (4): 435-441.
26. Yu C, Jin T, Chen W, Zhang P, Liu W, Guan H, Zhang J, Liu Q, Jiang A,. Identification of Sp1-elements in the promoter region of human homeobox gene NKX3.1. Mol Biol Rep 2009; 36 (8): 2353-2360.
27. Alipov G, Nakayama T, Ito M, Kawai K, Naito S, Nakashima M, Niino D, Sekine I,. Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas. Histopathology 2005; 46 (2): 202-208.
28. Dittmer J,. The biology of the Ets1 proto-oncogene. Mol Cancer 2003; 2: 29.
29. Attard G, Ang JE, Olmos D, de Bono JS,. Dissecting prostate carcinogenesis through ETS gene rearrangement studies: Implications for anticancer drug development. J Clin Pathol 2008; 61: 891-896.
30. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun X, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM,. Recurrent fusion of TMPRSS2 and ETS tanscription factor genes in prostate cancer. Science 2005; 310: 644-648.
31. Schreiber E, Matthias P, Muller MM, Schaffner W,. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989; 17 (15): 6419.
32. Weinmann AS, Bartley SM, Zhang T, Zhang MQ, Farnham PJ,. Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol 2001; 21 (20): 6820-6832.
33. Bieberich CJ, Fujita K, He WW, Jay G,. Prostate-specific and androgen-dependent expression of a novel homeobox gene. J Biol Chem 1996; 271 (50): 31779-31782.
34. Prescott JL, Blok L, Tindall DJ,. Isolation and androgen regulation of the human homeobox cDNA, NKX3.1. Prostate 1998; 35 (1): 71-80.
35. Black AR, Black JD, Azizkhan-Clifford J,. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001; 188 (2): 143-160.
36. Luscher B,. Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene 2001; 277 (1-2): 1-14.
37. Mirosevich J, Gao N, Matusik RJ,. Expression of Foxa transcription factors in the developing and adult murine prostate. Prostate 2005; 62 (4): 339-352.
38. Siu YT, Jin DY,. CREBâA real culprit in oncogenesis. FEBS J 2007; 274 (13): 3224-3232.
39. CGAP. The Cancer Genome Anatomy Project, Vol. 2009. National Cancer Institute; 1997,.
40. Polak P, Domany E,. Alu elements contain many binding sites for transcription factors and may play a role in regulation of developmental processes. BMC Genomics 2006; 7: 133.
41. Clark JP, Cooper CS,. ETS gene fusions in prostate cancer. Nat Rev Urol 2009; 6 (8): 429-439.
42. Narod SA, Seth A, Nam R,. Fusion in the ETS gene family and prostate cancer. Br J Cancer 2008; 99: 847-851.
43. Seth A, Watson DK,. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 2005; 41: 2462-2478.
44. Cangemi R, Mensah A, Albertini V, Jain A, Mello-Grand M, Chiorino G, Catapano CV, Carbone GM,. Reduced expression and tumour supressor function of the ETS transcription factor ESE-3 in prostate cancer. Oncogene 2008; 27: 2877-2885.
45. Gu X, Zerbini LF, Otu HH, Bhasin M, Yang Q, Joseph MG, Grall F, Onatunde T, Correa RG, Libermann TA,. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. Cancer Res 2007; 67 (9): 4219-4226.
46. Kibel AS, Faith D, Bova GS, Isaacs WB,. Mutational analysis of ETV6 in Prostate Carcinoma. Prostate 2002; 52: 305-310.
47. Hollenhorst PC, Shah AA, Hopkins C, Graves BJ,. Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev 2007; 21: 1882-1894.
48. Kunderfranco P, Mello-Grand M, Cangemi R, Pellini S, Mensah A, Albertini V, Malek A, Chiorino G, Catapano CV, Carbone GM,. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer. PloS ONE 2010; 5 (5): e10547.